Teladoc Health, Inc. Q3 FY2026 earnings call

• Strategic Priorities: Management outlined four key priorities: enhancing integrated care solutions (including the launch of Teladoc One), expanding hybrid care models (bolstered by the acquisition of Teledyne Health), pivoting BetterHelp toward an insurance-focused model, and driving operational excellence.
• Teladoc One Launch: Announced as a comprehensive, holistic care model leveraging AI-driven insights. Initial launch partners are active, with broader market availability expected in 2027.
• BetterHelp Insurance Pivot: The segment is shifting from cash-pay to an in-network insurance model. Insurance weekly sessions reached 27,000, implying an annualized run rate of over $140 million. Over 3,000 new therapists were added, bringing the credentialed network to over 11,000.
• Cost Efficiency: Advertising and marketing spend for BetterHelp decreased by 27% year-over-year. Management expects further sequential reductions in Q4 due to holiday dynamics and strategic shifts.
• Operational Excellence: Integrated care saw a 30% increase in member self-service interactions via AI. Net loss per share improved to $0.15 from $0.28 in the prior year period.
• M&A Activity: Completed the acquisition of Teledyne Health to expand U.S. hybrid care capabilities, combining technology with virtual clinical services in physical settings.

Integrated Care: Revenue was $398 million, representing a 2.3% year-over-year increase and exceeding the guidance midpoint. This growth was driven by strong international performance (double-digit growth), a 15% year-over-year increase in chronic care program enrollment, and visit revenue, partially offset by lower subscription revenue. Adjusted EBITDA was $75 million, up 13.3% year-over-year, with an adjusted EBITDA margin of 18.8%, significantly above guidance. BetterHelp: Revenue was $207 million, a 12.8% decline year-over-year, landing near the upper end of the guidance range. The decline was primarily due to lower cash pay revenue in both U.S. and non-U.S. markets, partially offset by strong insurance growth ($32 million, up $10 million sequentially). Average total paying users declined 12% year-over-year to 336,000. Adjusted EBITDA was $4 million, with a margin of 2.2%, supported by a 27% reduction in advertising and marketing spend.

• Consolidated Full-Year 2026 Revenue: Raised to $2.39 billion - $2.44 billion (midpoint up $13 million vs. prior guidance).
• Consolidated Full-Year 2026 Adjusted EBITDA: Raised to $277 million - $303 million (midpoint up $3 million vs. prior guidance).
• Consolidated Full-Year 2026 Free Cash Flow: Narrowed range to $135 million - $165 million (midpoint unchanged).
• Integrated Care Full-Year 2026 Revenue Growth: Maintained at 1.1% - 2.1%.
• Integrated Care Full-Year 2026 Adjusted EBITDA Margin: Raised to 16% - 16.6% (midpoint up ~30 basis points).
• BetterHelp Full-Year 2026 Revenue Decline: Revised to 12.9% - 16.1% (vs. 2025).
• BetterHelp Full-Year 2026 Insurance Revenue: Expected between $99 million - $105 million (midpoint up ~$4 million).
• BetterHelp Full-Year 2026 Adjusted EBITDA Margin: Expected at 2.7% - 4.3% (midpoint down ~30 basis points).
• Q4 2026 Consolidated Revenue: Expected between $569 million - $615 million.
• Q4 2026 Consolidated Adjusted EBITDA: Expected between $74 million - $100 million.
• 2027 Directional Commentary: BetterHelp aims for an annualized insurance revenue run rate of at least $200 million by the end of 2027, with sequential quarterly improvement expected throughout the year.

• BetterHelp Cash Pay Headwinds: Continued downward pressure on cash pay revenue due to challenging market conditions, consumer affordability issues, and strategic reductions in advertising spend.
• Execution Risk on Insurance Pivot: Scaling the insurance network requires significant investment in therapist credentialing, capacity expansion, and platform adjustments; failure to scale could limit growth.
• Macroeconomic and Regulatory Uncertainty: Health plans and employers are navigating rising costs, regulatory changes, and business uncertainties, which may impact selling cycles and bookings.
• Competitive Environment: Intense competition in virtual care and mental health services, particularly as other providers expand network access.
• Debt Maturity: A $1 billion convertible note matures in June 2027, requiring management to execute a two-phase repayment strategy subject to market conditions.

Q: Alan Lutz asked about the accelerating pace of therapist onboarding for BetterHelp’s insurance network (3,000 added in Q3) and whether scale benefits are being realized. / A: Chuck DeVita confirmed that the team is achieving scale benefits through accelerated credentialing and onboarding processes. He highlighted improvements in platform efficiency, reduced administrative burden, and evolving compensation models to ensure therapist retention and consistency. The focus remains on increasing active therapists accepting new patients across various markets and payers.

Q: Richard Close inquired why BetterHelp’s cash pay performance exceeded expectations in Q3 despite ongoing pressures, and how much of the Q4 guidance reflects proactive pivots versus external factors. / A: DeVita attributed the better-than-expected Q3 cash pay results to favorable customer acquisition costs and metric improvements from actions taken in Q2. However, he emphasized that Q4 guidance is heavily influenced by a planned significant reduction in advertising spend to align with insurance priorities, which historically correlates with lower cash pay user acquisition. Holiday ad dynamics also contribute to this decline.

Q: Lisa Gill sought clarity on the 2027 selling season for Integrated Care, specifically what clients are buying and how the new Teladoc One offering will factor into conversations and revenue. / A: DeVita explained that clients are seeking comprehensive, outcome-driven solutions that reduce fragmentation rather than point-specific products. Teladoc One, launching broadly in 2027, represents a holistic care model that allows Teladoc to demonstrate greater accountability and ROI. While initial pilot feedback is positive, full commercial impact is expected to build through 2027 and accelerate in 2028 due to standard sales cycles.

Q: Jessica Tassin asked if the $100 per insurance paid visit rate is stable and how the shift from Direct-to-Consumer (DTC) marketing to insurance affects SG&A and volume. / A: DeVita noted that reimbursement rates vary by payer and market but have been relatively consistent recently. The shift to a national insurance footprint allows for more efficient marketing messaging ('BetterHelp accepts insurance') compared to state-by-state cash pay campaigns. While SG&A investments are needed to scale credentialing and operations, management expects operating leverage to improve as the insurance business scales.

Q: Charles Rhyee questioned the differences in marketing strategies for insurance vs. cash pay and the long-term viability of the cash pay market as competitors leave. / A: DeVita explained that cash pay relied on broad national consumer campaigns, whereas insurance marketing must be tailored to specific state-level coverage, though a national footprint now allows unified messaging. He stated that while cash pay will persist for those avoiding stigma or lacking network access, the industry is moving toward insurance models due to affordability challenges. Teladoc intends to maintain both options but prioritizes insurance for durability.